Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TEAC correction - financials are correct

TEAC correction - financials are correct

posted on Nov 16, 2007 08:05AM

~$1B annual revenue company signing is worth noting. The legal staff of a corporation this size would not hand out cash if they didn't believe the ongoing litigation was a done deal in favor of TPL.

This represents votes by legal professionals, no doubt after substantial DD, supporting the validity of this patent potfolio. Makes me smile.

TEAC Annual Income Statements

All amounts in millions of US Dollars

YearRevenueGross ProfitOperating IncomeTotal Net IncomeDiluted EPS (Net Income)Mar 05Mar 04Mar 03
961.3 200.7 (28.3) (204.4) --
1,115.5 255.9 13.1 4.1 --
1,159.9 242.9 7.0 (23.2)

Share
New Message
Please login to post a reply